MedPath

MINT-LEVETIRACETAM SOLUTION

MINT-LEVETIRACETAM SOLUTION

Approved
DIN Number

02558416

Drug Class

Human

Market Date

N/A

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02558416
AIG Number0148843005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVETIRACETAMActive
Strength: 100 MG / ML
Monograph: LEVETIRACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.